Author: GALVmed M&E
Year: 2025
About this Publication:
The PLSHL 2 initiative was a landmark project for GALVmed in that it was the first time that a large vaccine manufacturer was partnered in a market development initiative. The approach was simple; introduce the manufacturer to a new, unserved market segment (very small-scale poultry farmers) and thereby grow their vaccine sales while improving poultry production for some of the poorest and most vulnerable farmers in India. Over a two-year period, approximately 129 million doses of poultry and other vaccines were sold to a cumulative total of approximately 3.9 million small-scale farmers in Odisha, Chhattisgarh, and Jharkhand States. The project was a successful business venture for the vaccine manufacturer and a valuable learning experience for GALVmed.
Grant: PLSHL2
Subject Areas: Monitoring and Evaluation
Keywords:
M&E, M&E. MonitoringandEvaluation, vaccinator, Study, PLSHL 2, Vaccinator study
Countries:
